Bay Colony Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bay Colony Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$412K	Sell	7,151 -134	-2%	-$7.69K	0.05%	306
2026 Q1	$442K	Sell	7,285 -15,618	-68%	-$910K	0.05%	288
2025 Q4	$1.24M	Buy	22,903 +16,702	+269%	+$803K	0.15%	133
2025 Q3	$280K	Sell	6,201 -4,208	-40%	-$197K	0.03%	409
2025 Q2	$482K	Sell	10,409 -23	-0.2%	-$1.13K	0.07%	247
2025 Q1	$626K	Buy	10,432 +178	+2%	+$10.4K	0.1%	201
2024 Q4	$580K	Buy	10,254 +865	+9%	+$48.3K	0.09%	218
2024 Q3	$486K	Buy	9,389 +2,288	+32%	+$107K	0.07%	240
2024 Q2	$295K	Sell	7,101 -11,998	-63%	-$537K	0.05%	296
2024 Q1	$1.04M	Sell	19,099 -1,103	-5%	-$56.2K	0.18%	123
2023 Q4	$1.04M	Sell	20,202 -11,576	-36%	-$608K	0.2%	114
2023 Q3	$1.84M	Buy	31,778 +151	+0.5%	+$9.25K	0.44%	52
2023 Q2	$2.02M	Buy	31,627 +402	+1%	+$27K	0.49%	44
2023 Q1	$2.13M	Sell	31,225 -4,158	-12%	-$293K	0.56%	40
2022 Q4	$2.55M	Sell	35,383 -442	-1%	-$33.3K	0.67%	31
2022 Q3	$2.55M	Sell	35,825 -112	-0.3%	-$8.13K	0.76%	25
2022 Q2	$2.65M	Sell	35,937 -3,231	-8%	-$246K	0.68%	29
2022 Q1	$2.86M	Buy	39,168 +2,258	+6%	+$152K	0.68%	29
2021 Q4	$2.3M	Buy	36,910 +2,017	+6%	+$118K	0.66%	34
2021 Q3	$2.06M	Buy	34,893 +6,720	+24%	+$443K	0.68%	36
2021 Q2	$1.88M	Buy	28,173 +501	+2%	+$32.7K	0.63%	37
2021 Q1	$1.75M	Buy	27,672 +2,538	+10%	+$158K	0.67%	34
2020 Q4	$1.56M	Buy	25,134 +564	+2%	+$34.7K	0.83%	21
2020 Q3	$1.48M	Buy	24,570 +7,552	+44%	+$455K	0.92%	20
2020 Q2	$1M	Sell	17,018 -716	-4%	-$42.8K	0.72%	42
2020 Q1	$989K	Buy	17,734 +1,323	+8%	+$80.9K	0.9%	28
2019 Q4	$1.11M	Buy	16,411 +4,401	+37%	+$252K	0.72%	31
2019 Q3	$609K	Buy	12,010 +7,544	+169%	+$355K	0.41%	82
2019 Q2	$203K	Buy	+4,466	New	+$208K	0.13%	198
2019 Q1	–	Sell	-4,398	Closed	-$229K	–	217
2018 Q4	$229K	Sell	4,398 -1,963	-31%	-$105K	0.19%	135
2018 Q3	$395K	Buy	6,361 +231	+4%	+$13.7K	0.3%	102
2018 Q2	$339K	Buy	+6,130	New	+$331K	0.24%	97

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Bay Colony Advisors's BMY Position: Q2 2026 in Review

Bay Colony Advisors reduced its Bristol-Myers Squibb (BMY) stake by 1.8% in Q2 2026, selling an estimated $7.69K and leaving 7,151 shares worth $412K. The position accounts for 0.05% of the portfolio, ranked #306.

Bay Colony Advisors first reported a position in BMY in Q2 2018 and has held it in 32 quarters since. The position peaked at $2.86M in Q1 2022. 879 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Bay Colony Advisors held 7,151 shares of Bristol-Myers Squibb worth $412K as of Q2 2026.
Bay Colony Advisors sold 134 Bristol-Myers Squibb shares in Q2 2026, an estimated $7.69K.
Bristol-Myers Squibb made up 0.05% of Bay Colony Advisors's portfolio in Q2 2026, its #306 holding.
Bay Colony Advisors first reported a position in Bristol-Myers Squibb in Q2 2018 and has held it in 32 quarters since.
Bay Colony Advisors's Bristol-Myers Squibb position peaked at $2.86M in Q1 2022.
879 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Bay Colony Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.